Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 8Unknown 5Completed 5Active not recruiting 3Terminated 2Not yet recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Mesothelioma 53Advanced Solid Tumors 53Solid Tumor 51Advanced Solid Tumor 41Mesothelioma, Malignant 38Solid Tumors 35Unspecified Adult Solid Tumor, Protocol Specific 27Carcinoma, Non-Small-Cell Lung 25Retinoblastoma 14Melanoma 14Esophageal Neoplasms 14Solid Tumor, Adult 13Sarcoma 12Ovarian Neoplasms 12Lung Neoplasms 11Carcinoma, Renal Cell 11Uterine Cervical Neoplasms 10Small Cell Lung Carcinoma 10Stomach Neoplasms 9Breast Neoplasms 9Colorectal Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Pancreatic Neoplasms 7Neoplasm Metastasis 7Advanced Solid Tumours 7Neoplasms 6Urinary Bladder Neoplasms 5Thyroid Neoplasms 5Solitary Fibrous Tumor, Pleural 5Malignant Solid Tumor 5

Interventions

pembrolizumab 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Locally Advanced or Metastatic Solid Tumors × Other solid neoplasm × Clear all
NCT05012618 2025-12-24

A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Chugai Pharmaceutical

Phase 1 Terminated
128 enrolled
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT04564417 2024-01-31

First-In-Human (FIH) Study of W0180 as Single Agent and in Combination With Pembrolizumab in Adults With Locally Advanced or Metastatic Solid Tumors

Pierre Fabre Medicament

Phase 1 Terminated
33 enrolled
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡